Phase 2 Study of EDG-5506 in Children and Adolescents With Duchenne Muscular Dystrophy Previously Treated With Gene Therapy (FOX)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The FOX study is a 2-part, multicenter, Phase 2 study of safety, pharmacokinetics, and biomarkers in children and adolescents with Duchenne muscular dystrophy previously treated with gene therapy including a randomized, double-blind, placebo-controlled Part A, followed by an open-label part B.
Epistemonikos ID: b836cbecfc9b68754d5b096b97482e32f6c6d350
First added on: May 15, 2024